Welcome to our dedicated page for Henry Schein news (Ticker: HSIC), a resource for investors and traders seeking the latest updates and insights on Henry Schein stock.
Henry Schein Inc. (symbol: HSIC) is the world's largest provider of healthcare products and services to office-based dental, animal health, and medical practitioners. As a Fortune 500® company and a member of the S&P 500® and NASDAQ 100® indexes, Henry Schein employs more than 18,000 team members and serves over one million customers globally. The company's offerings extend to dental laboratories, government and institutional healthcare clinics, and other alternate care sites.
Henry Schein operates through a centralized and automated distribution network, offering a comprehensive selection of more than 100,000 branded products and private-label products, as well as over 150,000 additional products available as special-order items.
The company is organized into two main segments: Healthcare Distribution and Technology & Value-Added Services. The Healthcare Distribution segment focuses on distributing consumable products, small equipment, and laboratory products. The Technology & Value-Added Services segment provides innovative software solutions and other technology services designed to help healthcare practitioners run their practices more efficiently and deliver high-quality care.
In recent years, Henry Schein has achieved significant milestones, including expanding its product range and forming strategic partnerships to enhance its service offerings. The company continues to innovate with exclusive technology solutions aimed at improving practice management and patient care.
Henry Schein (NASDAQ: HSIC) showcased a range of innovative dental and medical solutions at the AAOMS Annual Conference in New Orleans from September 12 to 17. The company highlighted products such as 3D printers, intraoral scanners, and anesthesia solutions, aiming to support oral and maxillofacial surgeons in enhancing patient care. Their team provided insights on customized solutions and showcased Henry Schein-brand products, promoting efficiency in surgical practices. The company emphasizes its commitment to being a trusted advisor to the OMS community.
Henry Schein, Inc. (Nasdaq: HSIC) announced the acquisition of Midway Dental Supply, enhancing its presence in the U.S. dental distribution market. The deal includes Midway Dental’s 7,000 customers and approximately
Henry Schein, Inc. (Nasdaq: HSIC), a leading provider of healthcare solutions for dental and medical practitioners, announced its participation in two key investor conferences in September 2022. The company will present at the Morgan Stanley 20th Annual Global Healthcare Conference in New York on September 12, followed by the Baird 2022 Global Healthcare Conference on September 14. Interested investors can access live webcasts of the presentations on the company's website, with replays available afterward. Henry Schein reported $12.4 billion in sales for 2021.
Henry Schein, a leading provider of health care products, has authorized a new share repurchase program of $400 million, adding to the previously announced $400 million program in May 2021, which was fully executed. This new authorization represents approximately 3.9% of the company's outstanding shares. As of August 17, 2022, the company had around 136 million shares outstanding. The initiative reflects the company's commitment to long-term value creation and its balanced capital allocation strategy, aiming to invest in growth and shareholder value.
Henry Schein, Inc. (Nasdaq: HSIC) announced the passing of Dr. E. Dianne Rekow, a Board member since 2014 and a leader in digital dentistry. Recognized for her contributions to the field, Dr. Rekow served on the Strategic Advisory Committee and was a prominent figure in aesthetic and restorative dentistry. Her extensive academic background included roles at King's College London and NYU, along with over 100 publications and several patents. This loss may impact the company’s strategic direction given her expertise in digital solutions for dental practices.
Henry Schein reported record second-quarter net sales of $3.0 billion, a 2.1% increase from the previous year. GAAP diluted EPS rose to $1.16 from $1.10 in Q2 2021. The company affirmed its full-year 2022 GAAP diluted EPS guidance of $4.75 to $4.91, indicating a growth of 7% to 10% over 2021. However, sales growth expectations were adjusted to 3% to 6% due to a strong dollar and declining demand for COVID-related products. Global Medical sales increased 10.3%, while Global Dental sales saw a 3.1% decrease.
Henry Schein has appointed Mark Hillebrandt as Vice President and Chief Digital Revenue Officer, focusing on e-commerce growth as part of the company’s 2022-2024 “BOLD+1” Strategic Plan. Hillebrandt will lead a new Digital Revenue Team aimed at enhancing online customer engagement and digital transactions. His role will support the advancement of Henry Schein's e-commerce tools, thereby improving customer experience and expanding the sales team's capabilities. Hillebrandt brings nearly 15 years of industry experience, previously holding leadership roles at Amazon and KaVo Kerr.
FAQ
What is the current stock price of Henry Schein (HSIC)?
What is the market cap of Henry Schein (HSIC)?
What does Henry Schein Inc. do?
How many team members does Henry Schein employ?
What segments does Henry Schein operate in?
How many products does Henry Schein offer?
Who are Henry Schein's primary customers?
What kind of technology solutions does Henry Schein provide?
Is Henry Schein a Fortune 500 company?
What stock market indexes is Henry Schein a part of?
How many customers does Henry Schein serve?
Does Henry Schein have any recent achievements?
